Navigation Links
InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
Date:4/22/2009

BILTHOVEN and NIJMEGEN, The Netherlands, April 22 /PRNewswire/ -- InteRNA Technologies B.V. and Radboud University Nijmegen Medical Centre have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for prostate cancer.

Under the research collaboration with professor Jack Schalken (Laboratory of Experimental Urology), InteRNA's unique lentiviral-based miRNA overexpression library will be applied in multi-parametric, high-throughput functional screening assays to identify the biological role of individual miRNAs and novel therapeutic targets in prostate cancer.

"We are very excited about this collaboration with professor Schalken, a renowned investigator in the prostate cancer field, as it allows for functional screens in diverse cell based assays embedded in a lab with extensive knowledge of prostate cancer," said Roel Schaapveld, Chief Operating Officer of InteRNA Technologies.

"Through the collaboration with InteRNA we gain access to a unique functional tool to identify microRNAs that are implicated in prostate carcinogenesis. Thus it is a truly symbiotic public-private partnership!" said professor Jack Schalken of Radboud UNMC.

About InteRNA Technologies B.V.

InteRNA Technologies B.V. actively explores and exploits opportunities to translate its unique collection of miRNAs and miRNA discovery and validation technologies into successful diagnostic, prognostic and therapeutic applications. The company's primary focus is to unravel the role of its proprietary miRNAs in cancer.

InteRNA Technologies was incorporated in 2006 by Aglaia Oncology Fund and has established close relationships with the research groups of its founders Edwin Cuppen, PhD, and Eugene Berezikov, PhD, of the Hubrecht Institute (Utrecht, the Netherlands), leading scientific groups in the field of miRNA research.

See for more information http://www.interna-technologies.com.

About Radboud University Nijmegen Medical Centre

Radboud University Nijmegen Medical Centre is a leading academic centre with expertise in medical science and healthcare. Expertise plays an essential part in our organisation and connects research, education and patient care. Our more than 8,500 staff and 3,000 students are committed and ambitious, helping to shape the future of healthcare and medical science. Driven by knowledge, empowered by people.


'/>"/>
SOURCE InteRNA Technologies BV
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Publication CONNEXION Director Selected to Present at the 5th Annual Meeting of the International Society of Publication Planning Professionals in Philadelphia
2. International team cracks mammalian gene control code
3. V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetowns Lombardi Comprehensive Cancer Center
4. MMR Information Systems, Inc. Announces 250,000 Membership Milestone and Granting of International Patents
5. Jet Lag Upsets Brains Internal Clocks
6. PRA International to Present Key Challenges for Safety Professionals at the World Drug Safety Congress: PRA Experts discussing REMS at Washington DC Conference
7. VirtualScopics Scientists to Present at International Society for Magnetic Resonance in Medicine 17th Scientific Meeting and Exhibition
8. Medical International Technology Inc. "MIT" announces a minimum of 6 million dollars exclusive agreement for a period of 5 years with a Malaysian Distributor for its Med-Jet(R) Needle-Free Jet-Injector
9. Frost & Sullivan and International Safety Equipment Association (ISEA) Present a Webinar on the Economy: Personal Protective Equipment Industry - Immune to Global Slowdown?
10. Inteck, Inc. has been Selected to Conduct Two Presentations at the 2009 International MUSE Conference
11. China YCT International (OTCBB: CYIG) Strengthens Corporate Governance With Establishment of Audit Committee and Appointments of Three New Independent Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance and ... and financial preparation services, is providing an update on a charitable event that ... City Rescue is a locally recognized nonprofit that provides shelter and care for ...
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
Breaking Medicine Technology: